Related Experiment Video
Updated: Jun 21, 2026
High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
Published on: January 4, 2015
Maintaining and engineering neural stem cells for delivery of genetically encoded therapy to brain tumors
Jennifer Katz1, Joseph Krueger, Brunhilde Felding-Habermann
1Burham Institute, La Jolla, CA, USA.
Abstract:
Despite advances for the treatment of cancer, the prognosis for patients suffering from malignant brain tumors remains dismal. High-grade neoplasms, such as gliomas, are highly invasive and spawn widely disseminated microsatellites that have limited the efficacy of surgical and adjunctive therapies. The cancer stem cell hypothesis suggests that conventional chemotherapeutic treatments kill differentiated and differentiating cells which often form the bulk of the tumor. One major concern is that the cells which give rise to the tumor, the cancer stem cells, remain untouched and may be responsible for a relapse of the disease. Therefore, an adjunctive therapy to current cancer treatment is critical for the survivability of patients suffering from brain tumors. We have successfully engineered tumor-tropic neural stem cells to deliver antineoplastic gene products directly to the tumor-producing cells. This potential therapeutic strategy may safely eradicate tumor-producing cells in the brain while minimizing damage to normal, healthy cells.
Insights
Engineered neural stem cells deliver cancer-fighting genes directly to brain tumor cells. This targeted approach aims to eradicate gliomas and prevent relapse, improving patient survival rates.
Area of Science:
- Oncology
- Neuroscience
- Biotechnology
Background:
- Malignant brain tumors, like gliomas, have a poor prognosis due to invasive growth and resistance to conventional therapies.
- The cancer stem cell hypothesis posits that these cells survive standard treatments and drive tumor recurrence.
- Current treatments often fail to eliminate the root cause of brain tumors, necessitating novel therapeutic strategies.
Purpose of the Study:
- To develop an innovative adjunctive therapy for malignant brain tumors.
- To engineer neural stem cells for targeted delivery of therapeutic agents to tumor cells.
- To investigate the potential of this approach to eradicate brain tumors while sparing healthy tissue.
Main Methods:
- Engineering tumor-tropic neural stem cells (NSCs).
- Developing NSCs to deliver antineoplastic gene products.
- Evaluating the efficacy and safety of engineered NSCs in targeting brain tumor cells.
Main Results:
- Successfully engineered neural stem cells that exhibit tumor-tropism.
- Demonstrated the capability of these engineered cells to deliver therapeutic gene products directly to tumor cells.
- This strategy shows potential for selective eradication of tumor-producing cells.
Conclusions:
- Engineered tumor-tropic neural stem cells offer a promising strategy for brain tumor treatment.
- This approach may effectively target and eliminate cancer stem cells, reducing relapse rates.
- The method has the potential to improve patient outcomes by minimizing damage to healthy brain tissue.
